Youngevity International Just Filed Its Quarterly Report: Basic loss per share...

Basic loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss attributable to common stockholders by the sum of the weighted-average number of common shares outstanding during the period and the weighted-average number of dilutive common share equivalents outstanding during the period, using the treasury stock method. Dilutive common share equivalents are comprised of stock options, restricted stock, warrants, convertible preferred stock and common stock associated with the Company's convertible notes based on the average stock price for each period using the treasury stock method. Potentially dilutive shares are excluded from the computation of diluted net loss per share when their effect is anti-dilutive. In periods where a net loss is presented, all potentially dilutive securities are anti-dilutive and are excluded from the computation of diluted net loss per share.

 

Potentially dilutive securities for the three months ended March 31, 2019 were 12,882,194. Potentially dilutive securities were 7,321,334 for the three months ended March 31, 2018.

 

The calculation of diluted loss per share requires that, to the extent the average market price of the underlying shares for the reporting period exceeds the exercise price of the warrants and the presumed exercise of such securities are dilutive to loss per share for the period, an adjustment to net loss used in the calculation is required to remove the change in fair value of the warrants, net of tax from the numerator for the period. Likewise, an adjustment to the denominator is required to reflect the related dilutive shares, if any, under the treasury stock method. During the three months ended March 31, 2019 and 2018, the Company recorded net of tax gain of $1,409,000 and $254,000, on the valuation of the Warrant Derivative Liability which has a dilutive impact on loss per share, respectively.

 

  

Three months ended

March 31,

(unaudited)

   2019  2018
Loss per Share – Basic      
Numerator for basic loss per share  $(12,274,000)  $(2,311,000)
Denominator for basic loss per share   27,577,576    19,744,144 
Loss per common share – basic  $(0.45)  $(0.12)
           
Loss per Share – Diluted          
Numerator for basic loss per share  $(12,274,000)  $(2,311,000)
Adjust: Fair value of dilutive warrants outstanding   (1,409,000)   (254,000)
Numerator for dilutive loss per share  $(13,683,000)  $(2,565,000)
           
Denominator for basic loss per share   27,577,576    19,744,144 
Plus: Incremental shares underlying “in the money” warrants outstanding   447,595    14,258 
Denominator for diluted loss per share   28,025,172    19,758,402 
Loss per common share – diluted  $(0.49)  $(0.13)

 

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Youngevity International makes a similar move, sign up!

Other recent filings from the company include the following:

Youngevity International, Inc. Announces Declaration Of Monthly Dividend For The 4Th Quarter 2021 For Series "D" Cumulative Redeemable Perpetual Preferred Stock - Oct. 13, 2021

Auto Refresh

Feedback